Products & Services · Year Seven

Multi-line and other specialty — Year Seven

Arch Capital Group Multi-line and other specialty — Year Seven increased by 23.5% to 2.1% in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from 1.7% to 2.1%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

Growth in this metric suggests successful retention of specialty business and effective pricing strategies in a mature segment.

Detailed definition

This metric quantifies the financial output of the multi-line and specialty insurance segment for the seventh year of th...

Peer comparison

Similar to long-term segment performance metrics provided by peer insurance companies with specialty underwriting divisions.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_seven

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value0.7%0.9%1.1%1.7%2.1%
QoQ Change+28.6%+22.2%+54.5%+23.5%
YoY Change+28.6%+22.2%+54.5%+23.5%
Range0.7%2.1%
CAGR+200.0%
Avg YoY Growth+32.2%
Median YoY Growth+26.1%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year seven?
Arch Capital Group (ACGL) reported multi-line and other specialty — year seven of 2.1% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year seven changed year-over-year?
Arch Capital Group's multi-line and other specialty — year seven increased by 23.5% year-over-year, from 1.7% to 2.1%.
What does multi-line and other specialty — year seven mean?
The financial performance of the multi-line and specialty insurance segment in the seventh year of the reporting period.